Transcript Highlights:

• In response to the decision, his food and drug and to the decision, his Food and Drug and FDA allowed
• The FDA must...
• The FDA must now move quickly to investigate the impact of this baby poison, not just on the baby, but
• why I've introduced legislation like HR 796, the Second Chance for Moms Act, which would require the FDA
• Under the Biden administration, the FDA recklessly ...removed the in-person dispensing requirement from

Keywords: U.S. House of Representatives Floor Proceedings on Wednesday, June 24, 2026, 1012, house, all

Transcript Highlights:

• A reason it's not completely FDA approved is that it's registered with the FDA, so a lot of emergency
• It is registered with the FDA, though.
• It is registered with the FDA, though.
• That's registered with the FDA?
• right other devices that's<00:11:36.440> registered<00:11:36.920> with<00:11:37.079> FDA

Keywords: The previous live stream for this committee experienced a technical issue. This is the complete meeting recording recovered from backups., 958, all

Summary: The committee first took up House Bill 44, “Landon’s Law,” sponsored by Rep. Candy Massaroni. The bill would allow schools to keep anti-choking devices such as LifeVac on hand while limiting liability. Testimony from Equal First Aid and LifeVac emphasized that choking is a leading cause of death for children, that the devices are noninvasive and FDA-registered, and that updated Red Cross guidance allows their use when standard rescue protocols fail or are not feasible. Lauren McCubbins, Landon McCubbin’s mother, gave emotional testimony about her 8-year-old son’s death from choking at school and urged the committee to give schools an added rescue option. Members asked questions about how the device works, whether the Heimlich maneuver remains part of the protocol, and whether the bill is limited to LifeVac or applies to similar devices. The bill was reported favorably, with a roll call vote showing unanimous support from members present. The committee then heard a bill sponsored by Rep. J. Baker aimed at reducing administrative burdens in schools and supporting teacher recruitment and retention. The measure would lengthen the required evaluation cycle for tenured teachers from every three years to every five years, provide teachers a copy of their employment contract upon request, streamline professional development provisions, update continuous school improvement plan filing requirements, restore schools’ ability to use Title II funds for certain programs after an unintended consequence of prior legislation, and require KDE to review reporting requirements and eliminate those not required by law. Rep. Baker said the bill was developed with teachers and administrators through a working group and is intended to reduce “check-the-box” tasks so educators can focus on instruction. Amanda Butler of Spencer County Schools and other educators testified that the changes would save time, preserve funding for mentor and induction programs, and reduce repetitive paperwork. Rep. Fleming asked for clarification on the longer evaluation cycle, and an educator witness explained that each evaluation involves pre-observation, observation, and post-observation time and that districts would still retain flexibility to evaluate more often if needed. No final vote on this bill was included in the transcript excerpt.

Transcript Highlights:

• FDA approval, and the bill removed hemp from the Drug Enforcement Administration's list of Schedule I
• He added that the language should mimic Senate Bill 5, which protects FDA-approved THC products, both
• FDA-approved products, any of those things, they're a safe harbor.
• We're almost there to get it—FDA dietary supplement regulations. "Okay.
• Those products have way above the amount that the FDA would even say induces psychosis. Thank you.

Summary: The House Committee on Public Health heard House Bill 5, a proposal to ban THC products outside the Texas Compassionate Use Program while allowing non-intoxicating CBD and CBG products under tighter regulation. Chair Van Deaver gave a lengthy background on the 2018 federal Farm Bill and Texas’s 2019 hemp law, arguing that the lack of guardrails allowed a large, unregulated THC market to develop. HB 5 would impose licensing fees, product registration, testing and inspection requirements, and restrictions intended to keep products away from children. Invited witnesses from law enforcement strongly supported the bill. Steve Dye of the Texas Police Chiefs Association and Brian Hawthorne of the Sheriffs’ Association of Texas argued that THC consumables are widely mislabeled, often far more potent than advertised, and linked to youth access, impaired driving, and organized crime. Both said regulation would be ineffective and would amount to legalization, while a ban would be easier for officers to enforce. They also emphasized support for the Texas Compassionate Use Program and said medical THC should remain available. Dr. Peter Stout of the Texas Association of Crime Lab Directors and Alice Amelot of Texas DPS testified as resource witnesses about forensic testing. They said current lab resources are already stretched thin, that quantitative testing for THC and related cannabinoids is expensive and time-consuming, and that a ban would simplify enforcement because labs could focus on presence/absence testing rather than concentration. Amelot said DPS labs are neutral on the bill but explained that mislabeled products and inaccurate certificates of analysis are common. Committee members asked about traffic safety, impairment, youth use, and the costs of enforcement and lab testing; witnesses repeatedly said the bill would reduce complexity for law enforcement but that any approach would still require more resources for labs.

Transcript Highlights:

• There's the FDA, OSHA, and health care authorities that monitor these devices.
• So they're classified as FDA class 3 and B and they are the highest hazard because they intentionally

Keywords: 996, all

Transcript Highlights:

• We're not talking about vaccines before they're FDA approved.
• We're talking about this, You know, the first step is the FDA approval.

Transcript Highlights:

• FDA.
• FDA approval with insurance coverage is the ultimate goal, but time is of the essence when so many lives
• H. 2203 underscores the need for data and oversight, but by tying a pilot program to FDA-approved pathways
• The FDA framework is designed for commercial drug approval for a single compound and for a single indication
• Supporting H. 4200 does not mean declaring psilocybin, quote-unquote, safe and effective in the FDA sense

Keywords: 995, all

Summary: The hearing opened with remarks from House Chair Mindy Domb and Senate Vice Chair Robyn Kennedy, who outlined procedures for the hybrid public hearing, noted the committee would hear testimony on 15 bills related to treatment settings, and recognized members present. The first major bill discussed was H. 4200, authorizing a pilot program for psychedelic-assisted treatment in licensed facilities. Representative Jim O’Day and witnesses from Control Z supported the bill, describing it as a tightly controlled, medically supervised pilot with DPH oversight, limited sites, and screening requirements. Committee members asked about the number of sites and whether Column Health still existed; witnesses said the bill contemplated three separate pilot programs and that Column Health no longer existed after being purchased by another company. The committee also heard testimony on S. 1405 to make the drug stewardship program permanent by removing its 2026 sunset date. Senator John Keenan and others said the program helps collect and safely dispose of unused medications, reduces diversion, and should remain in place because manufacturers should bear disposal costs. A member from Boston added support based on local concerns about people searching through bags for drugs, and Keenan explained the original sunset reflected pilot status and industry pushback. A large portion of the hearing focused on S. 1394 and H. 2193, which would strengthen implementation of the 2023 Roadmap for Behavioral Health Reform. The Children’s Mental Health Campaign, Parent/Professional Advocacy League, Massachusetts Association for Mental Health, and Elliott Community Human Services testified that the roadmap’s helpline, community behavioral health centers, and crisis services are important but unevenly implemented. They urged a single point of accountability within EOHHS, regular strategic planning, a public data dashboard, and financial analysis of the behavioral health system and the access and crisis intervention trust fund. Witnesses said commercial insurance often does not fully reimburse community behavioral health center services, making sustainability difficult, and asked for better coordination across agencies and crisis response systems. Committee members asked whether the roadmap includes substance use disorder; witnesses said it is intended to cover behavioral health broadly, including mental health and substance use. The committee also heard testimony on bills to ban aversives and on suicide prevention signage. Lisa Jean Graff testified in support of S. 1394 by urging a statewide ban on aversive practices, including electric shock, withholding food or bathroom access, and other painful interventions, arguing disabled people deserve the same protections from harm as others. Fonda Bryant and Carol McLean supported a bill requiring suicide prevention signs on tall parking garages, describing personal experiences and saying the signs could create a brief pause and connect people to 988 or other help. McLean said her son died by suicide from a parking garage and that signage might have made a difference. The committee also heard strong testimony in support of creating intensive stabilization and treatment units within DMH facilities (S. 1398/H. 2204), with the Massachusetts Nurses Association and a DMH nurse arguing that highly assaultive patients need specialized, more secure units to protect staff and other patients and to improve care. Additional testimony supported creating a dedicated board for licensed mental health counselors (H. 4696/S. 1382), with Rep. John Badger, the Mass Mental Health Counselors Association, and others saying LMHCs are a large and growing workforce that needs its own licensing board, clearer standards, and faster implementation of existing licensure reforms. The committee also heard extensive testimony on H. 2223 regarding benzodiazepines and non-benzodiazepine hypnotics. Survivors and advocates described severe withdrawal, lack of informed consent, cognitive harms, and long-term disability, while a physician supported the bill as a way to improve disclosure of risks. Finally, the committee heard multiple witnesses in favor of H. 2231/S. 1383 to establish peer-run respite centers statewide. Advocates and people with lived experience said peer respites provide non-coercive, home-like alternatives to hospitalization, can reduce trauma and repeated admissions, and may be especially important for marginalized communities; they also cited cost savings and existing positive outcomes from current respite programs. No votes or final committee actions were taken during the hearing portion reflected in the transcript.

Transcript Highlights:

• THE BILL AUTHORIZES SPECIFIC DOCTORS TO PERFORM FDA APPROVED STEM CELL THERAPIES FOR CERTAIN MEDICAL
• IT IS IMPORTANT TO CLARIFY STEM CELLS ARE FDA APPROVED, THIS ALLOWS PHYSICIANS TO HAVE A CONVERSATION
• THEN THEY SHUT DOWN BECAUSE THIS IS STILL REGULATED BY THE FDA SO THE FDA WILL COME IN AND MAKE SURE
• THERE ARE MANY, I'VE GOT A LIST OF ABOUT 20 OFF LABEL THERAPIES THAT HAVE FDA APPROVED USES FOR OTHER

Keywords: 999, senate, all

Transcript Highlights:

• So we tried to think, okay, if it's FDA-approved THC, that means it's gone through a medical review.
• The better way of crafting the legislation—and I do believe it is in here—is that any of the FDA-approved
• It's FDA dietary... ...supplement regulations.
• which can develop into bipolar disorder, even full-blown schizophrenia, leading these victims to need FDA
• We have agencies like the FDA, TABC, and DSHS.

Bills: HB5

Keywords: hemp, cannabinoids, regulation, occupational licenses, consumable products, marketing, criminal offenses, labeling requirements, health and safety, 997, house, all

Transcript Highlights:

• Over the years, the departments and also our organization and FDA have tested more than 500 products,
• c><01:07:50.559> have<01:07:50.799> tested<01:07:51.280> more organization and FDA
• have tested more organization and FDA have tested more than<01:07:52.240> 500<01:07:53.359>
• allows which is one threshold that FDA allows which is one parts<01:08:07.119> per<01:08:07.359
• premises that can persist for years, and legal liability when selling products that don't meet the FDA

Keywords: 1187, senate, all

Transcript Highlights:

• The FDA at that time also approved a companion diagnostic, which was a specific biomarker test to identify
• These are products that the FDA has evaluated and authorized for sale because they help adult smokers
• People have the right to use FDA-authorized products.
• People have the right to use FDA-authorized products.
• People have the right to use FDA-authorized products.

Keywords: 910, house, all

Summary: The joint hearing covered HB 553 on biomarker testing coverage, HB 556 on colorectal cancer screening access, and later HB 712 on 340B drug pricing. For HB 553, the American Cancer Society Cancer Action Network, patient advocates Natalie Heyman and Susan Hirano, a surgical oncologist, and the American Lung Association strongly supported the bill, arguing that biomarker testing should be covered when ordered by a doctor and guided by current evidence. DHS and several insurers offered comments and requested amendments, with DHS saying it appreciated the intent but wanted changes. The committees then voted to pass HB 553 with amendments, including a House draft and a defective date of July 1, 3000; both the House Health and Human Services and Homelessness committees adopted the recommendation unanimously. For HB 556, testimony focused on closing gaps in colorectal cancer screening, especially for uninsured and underinsured patients who can get stool-based screening but then cannot access follow-up colonoscopies. Community Clinic of Maui, ACS CAN, and the American Cancer Society supported the bill, with ACS CAN urging a program similar to the breast and cervical cancer control program and offering amendments. DHS requested that the program and appropriation not conflict with executive budget priorities, and the committees noted technical amendments, a defective date, a blank appropriation amount, and corrections changing Medicare references to Medicaid. HB 556 was also passed with amendments by both committees. The hearing then moved to HB 712 on 340B drug pricing and contract pharmacies. The Department of Health and the Attorney General’s office expressed concern that the bill would require the state to regulate private commercial activity and said the department lacked the expertise and resources to implement it as written, suggesting it might belong in a different statutory section. In contrast, PhRMA opposed the bill, while Hawaii Pacific Health and Hawaii Island Community Health Center supported it, saying 340B savings are important for hospital services and patient access to low-cost medications, especially where manufacturers have restricted shipments to contract pharmacies. No vote on HB 712 was taken in the portion provided.

Transcript Highlights:

• FDA and waived under the Clinical Laboratory Improvement Amendments, and also has various outlined guidance
• FDA and waived under the Clinical Laboratory Improvement Amendments, and also has various outlined guidance

Keywords: 1182, all

Summary: The caucus reviewed a long list of Senate and House bills, many of them on consent or with strike-everything amendments. Topics included advanced air mobility for border security (SB 1457), raising the off-highway vehicle weight limit to 3,500 pounds while striking a proposed law enforcement fund (SB 1519), school property leases and a trampoline court safety citation change (HB 2383), electronic monitoring in health care facilities (SB 1041), dental school complaint handling and board jurisdiction limits (SB 1168), pharmacist-authorized testing and HIV prevention guidance (SB 1713), school district insurance/self-insurance requirements (SB 1497), reporting-requirement cleanup for education statutes (HB 2203), historic neighborhood housing zoning (SB 1118), construction contract payment protections in revitalization districts (SB 1189), timeshare salesperson licensing (SB 1274), workers’ compensation notice and recordkeeping (SB 1428), property tax disability exemption clarifications (HB 2120), insurance modeling/data organization requirements (HB 2174), HOA rules on chickens and pet breed restrictions (SB 1582), first responder death benefits for law enforcement pilots (SB 1503), and changes to virtual veterinary prescribing periods (SB 1286). Members generally asked clarifying questions, and several sponsors were said to intend to concur or refuse amendments, with HB 2010 headed to conference because the sponsor would not accept the Senate’s five-year refund window. On the second calendar, the committee heard HB 2176 on health facility complaint investigations, allowing DHS to investigate older complaints involving alleged abuse; HB 2050 on radiologic technologists and radiologist assistants, restoring direct supervision requirements with limited general-supervision exceptions; HB 2010 on digital goods, where the Senate reduced a refund window from 10 years to five and the sponsor planned to refuse; HB 2875 on unmanned aircraft, expanding airport drone-delivery buffer rules from one mile to two and a half miles and requiring airport consultation; HB 2428 on county certification of emission reduction credits, clarifying participation is voluntary and limiting new credits if fleet participation becomes mandatory; and HB 2877, which was struck and replaced with a veterinary technician certification pathway requiring 4,000 supervised work hours and allowing nonprofit curriculum evidence. Several members noted support or opposition based on prior votes or policy concerns, but no roll-call votes were taken in the caucus itself.

Transcript Highlights:

• Therapeutic is defined by FDA approved indications.
• These indications are FDA approved, and there are clinical studies vouching for their use and safety

Bills: SB1117, SB1373, SB672, SB1986, SB1098, SB626, SB1784, SB2480, SB2487, SB437, SB660

Keywords: dentistry, botulinum toxin, aesthetic treatments, dental regulation, training, medical staff privileges, hospital administration, healthcare regulation, Texas Health and Safety Code, consistency in privileges, SB 672, Texas hospital emergency operations plan, hospital diversion, emergency department, cyberattack, cyber security, power outage, electrical outage, patient diversion, hospital preparedness

Transcript Highlights:

• <05:57:46.878> So FDA to date clinical trials combined.
• So FDA to date clinical trials combined.
• needs to enlighten the federal the FDA needs to enlighten the federal the FDA uh<06:21:56.638>
• He sent his FDA still find appalling.
• The rate of serious adverse events is about 22 times higher than the rate stated by the FDA.

Keywords: U.S. House of Representatives Floor Proceedings on Tuesday, June 24, 2025, 1012, house, all

Transcript Highlights:

• Fda Lee's biometric identification solution also known as biz handles the storage and fingerprint things
• The submitted to FDA Lee, this standardized data, what set the foundation for information that will be
• number of agencies are still in the process of transitioning that have start actually submitting data to FDA

Keywords: 999, senate, all

Transcript Highlights:

• The FDA at fda.gov said the following. about delta 8 THC.
• FDA has received adverse reports involving delta 8.
• I was heavily medicated with a cocktail of FDA approved pharmaceuticals.
• So FDA criteria is 1,000 parts per million.
• I'll remind all the senators here that CBD has been FDA approved.

Bills: SB3, SB810, SB965, SB1073, SB1119, SB1505, SB 3

Keywords: Texas Education Code, public schools, school district, open-enrollment charter school, teacher speech, employee speech, biological sex, pronouns, gender identity, retaliation, discipline, workplace protections, school personnel, education policy, LGBTQ, transgender, charter schools, SB 965, religious speech, prayer

Transcript Highlights:

• So therapeutic is defined by FDA approved indications.
• Um, these indications are FDA approved and there's clinical studies vouching their, um, use and safety

Transcript Highlights:

• At that time there were two drugs that were FDA approved that were covered by the Medicaid Program, and
• At that time there were two drugs that were FDA approved that were covered by the Medicaid Program, and
• At that time there were two drugs that were FDA approved that were covered by the Medicaid Program, and
• States where Medicaid does cover weight loss drugs: we are required to cover any FDA-approved drug for
• have to cover drugs that are um FDA have to cover drugs that are um FDA approved<01:16:13.400>

Keywords: 1183, house

Transcript Highlights:

• We have been working with the FDA to start a new program.
• We have been working with the FDA to start a new program.
• We have been working with the FDA to start a new program.
• We have been working with the FDA to start a new program.
• We have been working with the FDA to start a new program.

Keywords: 910, house, all

Summary: The House Committee on Higher Education met at the University of Hawaiʻi’s Bachman Hall and heard testimony on several UH-related bills. HB 542 would expand the Hawaiʻi Promise Program to provide unmet-need scholarships at four-year UH campuses. UH system officials, the UH Student Caucus, and a Honolulu Community College student testified in support, emphasizing college affordability, student retention, and workforce needs. Committee members asked about current program data, eligibility, transfer patterns, and cost; UH said it had data available, noted about 10% of current Hawaiʻi Promise students transfer to four-year campuses, and estimated the full expansion would cost about $12 million. UH also suggested a possible alternative of focusing on transfer opportunities from two-year to four-year campuses. The committee then heard HB 840, which concerns athletics appropriations for UH. UH Mānoa and UH Hilo supported the bill. UH officials said the funding would help cover recurring athletics operating costs, women’s sports travel and recruiting, Austin Awards, and a new nutrition fueling station, while Hilo said the money would help with travel, per diem, and conference-related costs. Members asked about the history of the athletics funding, the difference between Austin Awards and special talent waivers, NIL planning, and whether the appropriation should be restored to the base budget. UH explained that a $4 million athletics appropriation was originally made in 2018 or 2019, later removed from the base, and has been reappropriated annually since then. Finally, the committee heard HB 842, which would fund three additional permanent mental health practitioner positions at UH Mānoa’s Counseling and Student Development Center. UH supported the bill, and Academic Labor United and a high school student testified in favor, citing student stress, overwork, and the need for more counseling access. In questions, members discussed the current counselor-to-student ratio, recruitment challenges in a tight labor market, and strategies for hiring, including looking at candidates on soft-money grants who may be seeking stable employment. No votes or final committee actions were taken during the portion of the meeting provided.

Transcript Highlights:

• I was immediately prescribed an FDA-approved oral medication that targets my cancer cells as the first
• And because of the strong and tireless work of advocates, the FDA, and now the National Comprehensive
• Currently, the only FDA-approved treatments that slow the progression of Alzheimer's disease target amyloid
• Since 2013, we have seen over 20 FDA-approved drugs targeting over a dozen different lung cancer biomarkers
• our testing was supported by research funding, even if we knew the results were being used to guide FDA-approved

Keywords: 995, all

Summary: The Joint Committee on Financial Services held a lengthy public hearing with testimony on a wide range of health insurance and access-to-care bills. Early testimony focused on prescription drug pricing and pharmacy reimbursement, with supporters of H. 1326 arguing that pharmacy benefit managers and MassHealth managed care arrangements reimburse independent pharmacies too little, contributing to pharmacy closures and “pharmacy deserts.” The committee also heard repeated support for H. 1151/S. 742 on cognitive rehabilitation for acquired brain injury, H. 1288/S. 716 on telehealth parity for nutrition counseling, H. 1309/S. 761 on full-spectrum pregnancy care without cost-sharing, H. 1312 on insurance coverage for doula services, H. 309 on prompt access to health care by removing deductibles for certain services, H. 809/H. 1227 on biomarker testing, H. 1162/S. 810 on reducing inequities in access to medical procedures by limiting insurer cuts tied to Modifier 25, and S. 726 on insurance coverage for mobile integrated health. Testifiers included legislators, physicians, pharmacists, dietitians, emergency and rehabilitation clinicians, and patients and family members. Supporters of the brain injury bill said cognitive rehabilitation is medically necessary, improves long-term outcomes, and can reduce institutional care and public costs; they noted the bill has been heard repeatedly and has support from the Brain Injury Commission and prior favorable committee action. Supporters of the pregnancy care and doula bills described out-of-pocket costs as a barrier to maternal health and shared personal stories of high bills and unmet support needs. Biomarker testing advocates and cancer patients said coverage gaps deny patients access to precision treatment, can lead to avoidable suffering, and should be standardized across insurers; several speakers said insurers often deny claims despite clinical benefit. Dermatology witnesses said insurers’ use of Modifier 25 cuts reimbursement for same-day evaluation and procedure visits, forcing separate appointments and increasing patient burden. Mobile integrated health supporters described home-based care as a way to reduce emergency department use and hospital readmissions, especially for patients with transportation or mobility barriers. No votes or formal committee actions were taken during the hearing itself.

Transcript Highlights:

• In fact, we have filed a new dietary ingredient, which is known as an NDIN with the FDA.
• I know the federal FDA or DEA does the regulations. Is this considered a narcotic by them?
• For the question about is it a narcotic considered by the FDA, it is not.
• The FDA supports raw kratom. They've even said that on their talk about kratom.
• The FDA supports raw kratom. They've even said that on their talk about kratom.

Bills: SB1067, SB1234, SB1285, SB1295, SB1392, SB1413, SB1436, SB1470, SB1476, SB1489, SB1512, SB1535, SB1540, SB1556, SB1568, SB1569, SB1570, SB1573, SB1585, SB1609, SB1627, SB1634, SB1635, SB1644, SB1647, SB1648, SB1650, SB1653, SB1654, SB1655, SB1656, SB1657, SB1658, SB1661, SB1662, SB1664, SB1666, SB1667, SB1669, SB1709, SB1720, SB1723, SB1725, SB1743, SB1746, SB1748, SB1755, SB1786, SB1820, SB1822, SB1829, SCR1027, SCR1040, SCR1048

Keywords: tax lien, property tax lien, real property tax lien, foreclosure, right of redemption, redeem, excess proceeds, county abatement lien, abatement lien, lien priority, assessment lien, easement, county treasurer, certificate of purchase, tax delinquency, delinquent property taxes, property owner equity, judgment foreclosure, title report, Arizona Revised Statutes

Summary: The committee approved the minutes and then took up a long agenda of election, criminal justice, corrections, and county-government bills. Early election measures included SB 1436, requiring ballot language for certain school override and bond elections to estimate the secondary property tax impact; SB 1568, requiring election systems’ internal clocks to stay within 60 seconds of official time and making violations a misdemeanor; SB 1569, limiting special election board members from collecting or processing voter registration while assisting confined voters; and SB 1746, requiring voting centers to supplement rather than replace precinct polling places, requiring public offices and schools to provide polling space, and closing schools on primary and general election days for in-service training. SB 1436 and SB 1568 were eventually given do-pass recommendations, SB 1569 also passed committee, and SB 1746 passed despite concerns raised about school safety and access. Some bills were held earlier in the meeting and voted on later after testimony concluded. The committee also heard SB 1295, which would allow the Department of Corrections to release certain seriously ill inmates to contracted medical institutions if they qualify for ALTCS, with an amendment replacing disability language with illness-based criteria; the sponsor described it as a cost-saving measure that could shift care costs to federal programs. SB 1067, the so-called Gila County blight bill, would let counties place abatement costs for rubbish, debris, and dilapidated buildings on property tax bills and liens; county officials testified that it would help recover cleanup costs for blighted properties and heirs’ property, and it passed unanimously. SB 1413 would remove the $100,000 cap on restitution for serious injury or death caused by moving violations and passed after the sponsor said the cap had already been found unconstitutional. SB 1476 would make child neglect a class six felony when a custodian exposes a newborn to dangerous or narcotic drugs or causes fetal alcohol syndrome; supporters framed it as accountability and child protection, while opponents warned it could deter treatment and worsen family separation. The bill passed on a split vote. Later, the committee considered several criminal-justice and public-safety bills. SB 1512 would expand the definition of vulnerable adult and broaden “position of trust and confidence” for theft cases involving seniors and other vulnerable adults; testimony highlighted scams and exploitation of grieving or isolated elders, and the bill passed. SB 1585 would regulate sex-offender-specific evaluations, treatment, and polygraph services through the Sex Offender Management Board, add a surcharge fund and assessment on sexual-offense convictions, and appropriate funds to DPS; supporters said it would create uniform standards, while opponents questioned the need for additional fees, and it passed. SB 1662 would require probation conditions to be the least restrictive necessary and tailored to a defendant’s risk and needs; supporters from the Justice Action Network and criminal-defense advocates said it would improve rehabilitation and public safety, and it passed. The committee also began SB 1664, which would change constable petition-signature requirements in Maricopa and Pima counties, but the transcript cuts off before the full discussion and vote on that bill.